Lars Toleikis

Person

Bundlesland, DE

People

Patents Grantslast 30 patents

Information Patent Grant
MMP13 binding immunoglobulins
- Patent number 12,129,308
- Issue date Oct 29, 2024
- Merck Patent GmbH
- Francis Descamps
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polypeptides binding ADAMTS5, MMP13 and aggrecan
- Patent number 11,813,307
- Issue date Nov 14, 2023
- Merck Patent GmbH
- Soren Steffensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aggrecan binding immunoglobulins
- Patent number 11,603,401
- Issue date Mar 14, 2023
- Ablynx N.V.
- Soren Steffensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody directed to FGFR1
- Patent number 11,597,771
- Issue date Mar 7, 2023
- Christel Iffland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific antibodies for enhanced tumor selectivity and inhibitio...
- Patent number 11,235,063
- Issue date Feb 1, 2022
- Merck Patent GmbH
- Achim Doerner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant anti-MUC1 antibodies
- Patent number 9,546,217
- Issue date Jan 17, 2017
- MAB FACTORY GMBH
- Christian Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific aptamers mediating tumour cell lysis
- Patent number 8,969,318
- Issue date Mar 3, 2015
- Merck Patent GmbH
- Lars Toleikis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
VHH-BASED NKP30 BINDERS
- Publication number 20240287177
- Publication date Aug 29, 2024
- Merck Patent GmbH
- Stefan ZIELONKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDES BINDING ADAMTS5, MMP13 AND AGGRECAN
- Publication number 20240181006
- Publication date Jun 6, 2024
- Merck Patent GmbH
- Soren STEFFENSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF
- Publication number 20240010749
- Publication date Jan 11, 2024
- Merck Patent GmbH
- Jan ANDERL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGGRECAN BINDING IMMUNOGLOBULINS
- Publication number 20230312694
- Publication date Oct 5, 2023
- Ablynx N.V.
- Soren Steffensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USE...
- Publication number 20230310629
- Publication date Oct 5, 2023
- Merck Patent GmbH
- Christine Knuehl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NKP30 BINDERS
- Publication number 20230287082
- Publication date Sep 14, 2023
- Merck Patent GmbH
- Stefan Zielonka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITIO...
- Publication number 20220111064
- Publication date Apr 14, 2022
- Merck Patent GmbH
- Achim DOERNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGGRECAN BINDING IMMUNOGLOBULINS
- Publication number 20220089703
- Publication date Mar 24, 2022
- Ablynx N. V.
- Soren Steffensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGGRECAN BINDING IMMUNOGLOBULINS
- Publication number 20210115117
- Publication date Apr 22, 2021
- Ablynx N. V.
- Soren Steffensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDES BINDING ADAMTS5, MMP13 AND AGGRECAN
- Publication number 20210008160
- Publication date Jan 14, 2021
- Merck Patent GmbH
- Soren STEFFENSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MMP13 BINDING IMMUNOGLOBULINS
- Publication number 20200190216
- Publication date Jun 18, 2020
- Merck Patent GmbH
- Francis DESCAMPS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGGRECAN BINDING IMMUNOGLOBULINS
- Publication number 20200140532
- Publication date May 7, 2020
- Ablynx N. V.
- Soren Steffensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODY DIRECTED TO FGFR1
- Publication number 20190367620
- Publication date Dec 5, 2019
- Merck Patent GmbH
- CHRISTEL IFFLAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C-MET ANTIBODIES AND ANTIBODY DRUG CONJUGATES THEREOF FOR EFFI...
- Publication number 20190248907
- Publication date Aug 15, 2019
- Merck Patent GmbH
- Achim DOERNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITIO...
- Publication number 20180326085
- Publication date Nov 15, 2018
- Merck Patent GmbH
- Achim DOERNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC APTAMERS MEDIATING TUMOUR CELL LYSIS
- Publication number 20140039042
- Publication date Feb 6, 2014
- Merck Patent GmbH
- Lars Toleikis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT ANTI-MUC1 ANTIBODIES
- Publication number 20110318757
- Publication date Dec 29, 2011
- Christian Behrens
- C07 - ORGANIC CHEMISTRY

Lars Toleikis

Person

Patents Grantslast 30 patents

MMP13 binding immunoglobulins

Polypeptides binding ADAMTS5, MMP13 and aggrecan

Aggrecan binding immunoglobulins

Monoclonal antibody directed to FGFR1

Bi-specific antibodies for enhanced tumor selectivity and inhibitio...

Recombinant anti-MUC1 antibodies

Bispecific aptamers mediating tumour cell lysis

Patents Applicationslast 30 patents

VHH-BASED NKP30 BINDERS

POLYPEPTIDES BINDING ADAMTS5, MMP13 AND AGGRECAN

ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF

AGGRECAN BINDING IMMUNOGLOBULINS

BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USE...

NKP30 BINDERS

BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITIO...

AGGRECAN BINDING IMMUNOGLOBULINS

AGGRECAN BINDING IMMUNOGLOBULINS

POLYPEPTIDES BINDING ADAMTS5, MMP13 AND AGGRECAN

MMP13 BINDING IMMUNOGLOBULINS

AGGRECAN BINDING IMMUNOGLOBULINS

MONOCLONAL ANTIBODY DIRECTED TO FGFR1

ANTI-C-MET ANTIBODIES AND ANTIBODY DRUG CONJUGATES THEREOF FOR EFFI...

BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITIO...

BISPECIFIC APTAMERS MEDIATING TUMOUR CELL LYSIS

RECOMBINANT ANTI-MUC1 ANTIBODIES